Ondansetron for Prevention of Post-Operative Nausea and Vomiting (PONV) in General Surgery Patients
Muhammad Naeem, Rafia Tabassum, Muhammad Saleh Khaskheli, Aijaz Hussain Awan, Munazzah Meraj, Rao Irfan
Journal of Pharmaceutical Research International · pp. 35–39 · Published 24 Nov 2021
10.9734/jpri/2021/v33i51B33508Abstract
Aim: To determine the efficacy of single dose ondansetron in preventing PONV in patients. Methodology: In this cross sectional study 49 patients were given Ondansetron. Every patient was evaluated for PONV at 1, 2, 3, 6, 12 and 24 hours post operatively. This study was conducted at General surgery operation theatres and surgical wards I, II, III and Department of Anesthesia and SICU Peoples University of Medical & Health Sciences for women Nawabshah, District Shaheed Benazirabad, Sindh. Results: A sample of 49 patients with age between 20-60 years (mean age 43.72±5.67 years), 35% male and 65% female was included in this study. In this study ondansetron was given (N=49) 4 mg I/V before induction. Regarding complications there was not significant (p ≤0.05) POVN was observed. Conclusion: Our study results showed in patients who received ondansetron regarding frequency of post operative complications (PONV) showed insignificant results as no p-value is found to be ≤0.05.It was concluded that a single dose of ondansetron is very effective in preventing PONV in general surgery patients.
Cited by 0
No indexed citations yet.
Related research
- A Randomized Placebo Controlled Study to Determine the Efficacy of Oral Diclofenac Sodium in the Treatment of Symptomatic Osteoarthritis of the Knee in Nnewi, South Eastern Nigeria — shares topic coverage
- Bacteriological and Fungal Evaluation of Three Brands of Disinfectants Sold in Calabar Municipality, Cross River State — shares topic coverage
- Drug Interactions, Safety and Efficacy of Probiotics — shares topic coverage
- The Efficacy of the Volume of Hyperbaric Bupivacaine Used and Its Influence on Spinal Anaesthesia Induced Hypotension during Caesarean Section — shares topic coverage
- A Comparison of Efficacy of Two Brands of Enoxaparin in COVID-19 Patients: A Pilot Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.